A company whose hero product is an AI software platform for personalised breast cancer screening is now headed by a woman – a rare thing in health tech globally, despite the dominance of women in broader healthcare.
Wellington-based, Australian-listed cancer software company Volpara Health
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
